It is evident that targeting the NF-κB signaling pathway, along with upstream pathways such as PI3K/AKT and MAPK signaling pathways represents crucial therapeutic strategies for managing osteoarthritis using sophocarpine. Here, NFKB1 is linked to osteoarthritis.